GE: collaboration with optellum in lung cancer

(CercleFinance.com) - GE Healthcare, a specialist in medical imaging solutions, and Optellum, a specialist in AI-based decision support for the early diagnosis and optimal treatment of lung cancer, today announced that they have signed a letter of intent to collaborate on advancing the precision diagnosis and treatment of lung cancer.


The companies seek to address one of the biggest challenges in lung cancer diagnosis - helping providers determine the malignancy of a lung nodule.
By combining their solutions, both partners believe they can create precision healthcare.

GE's extensive clinical network can accelerate the deployment of the Optellum platform and could enable a revolutionary redefinition of early lung cancer treatment for clinicians and patients worldwide, GE's partner Optellum said.



Copyright (c) 2021 CercleFinance.com. All rights reserved.